Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%. New ...

Focus ultrasound (FUS) has the potential to revolutionise therapy to the same degree that magnetic resonance imaging (MRI) ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that ...

CRUK has invested more than £43 million into the RadNet programme since it was launched in 2019, and Manchester is one of ...

Watertown, Massachusetts-based Disc has agreed with the FDA that it will use average monthly time in sunlight during the last ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for ...

The Danish pharma group is pledging $285 million in upfront and milestone payments for the lead GLP-1 asset in the ...

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics.

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively. Ono's deal with South Korean antibody-drug conjugate ...

As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand. Artificial intelligence (AI) and machine learning (ML) drive these devices and the ...

The Federal Trade Commission (FTC) is asking for information from wholesalers and other middlemen in the pharmaceutical supply chain in an investigation into worsening shortages of generic medicines.